Acurx Pharmaceuticals Inc...

0.68
-0.03 (-4.16%)
At close: Mar 03, 2025, 3:59 PM
0.67
-1.87%
Pre-market: Mar 04, 2025, 08:11 AM EST

Acurx Pharmaceuticals Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19
Cash & Equivalents 7.47M 9.11M 12.96M 3.18M 2.48M
Short-Term Investments n/a n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a
Other Long-Term Assets n/a n/a n/a n/a n/a
Receivables 129.16K n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a
Other Current Assets 105.78K 264.95K 295.3K 48.61K 48.1K
Total Current Assets 7.71M 9.38M 13.25M 3.22M 2.53M
Property-Plant & Equipment n/a n/a n/a n/a n/a
Goodwill & Intangibles n/a n/a n/a n/a n/a
Total Long-Term Assets n/a n/a n/a n/a n/a
Total Assets 7.71M 9.38M 13.25M 3.22M 2.53M
Account Payables n/a 29.54K 63.37K n/a 2.3K
Deferred Revenue n/a n/a n/a n/a n/a
Short-Term Debt n/a n/a n/a 16.63K n/a
Other Current Liabilities 3.04M 2.03M 780.53K 455.93K 1.71M
Total Current Liabilities 3.04M 2.06M 843.91K 472.56K 1.71M
Long-Term Debt n/a n/a n/a 49.88K n/a
Other Long-Term Liabilities n/a n/a n/a n/a n/a
Total Long-Term Liabilities n/a 2.06M n/a 49.88K n/a
Total Liabilities 3.04M 2.06M 843.91K 522.43K 1.71M
Total Debt n/a n/a n/a 66.5K n/a
Common Stock 14.47K 11.63K 10.22K 16.5M 10.02M
Retained Earnings -53.22M -38.64M -26.55M -13.8M -9.2M
Comprehensive Income n/a -38.64M -26.55M -13.8M -9.2M
Shareholders Equity 4.67M 7.32M 12.41M 2.7M 819.85K
Total Investments n/a n/a n/a n/a n/a